Loading…
Hosted by Flavio Rump · 🇺🇸 US · EN-US · 15 episodes
Established thought leaders with verified media credentials.
In this podcast, entrepreneur and angel investor Flavio Rump discusses the biggest bottlenecks and the future of biotech by speaking with some of the sharpest, most innovative minds in biotechnology and related fields.
Flavio Rump hosts Bio2040 - Bottlenecks & Future of Science, Healthcare & Biotech, a science show with 15 episodes published.
One of the most exciting conversations I have had all year. Abhi, co-founder and CEO of roots is is a software engineer turned farmer who is really pushing LLMs to the edge of their abilities. In this interview, we disco
In Bio2040’s latest episode we had the chance to talk to Sam Lee, a long-time veteran of the biotech space. This episode covers some of the history and fundamentals of the synthetic biology and biomanufacturing space.
What are the main challenges in translating scientific innovation from the bench-side to the bedside? Physician and long-term Pharma executive Nadine Martin is now in charge of innovation management at sitem-insel AG. A
SEED2019 is a scrappy conference targeting innovation within the science publishing & funding process. It will bring together a diverse set of stakeholders and be followed by an incubator to implement the best ideas. We
How Open Source Drug Discovery can lower the risk and cost of drug discovery. M4K Pharma is pioneering a completely new model, where patents are not filed but data is shared. Yet they are still able to make money.
Peer review is opaque and a large frustration for many scientists. Preprints are becoming more prevalent, but we still need to assess them critically. We shed light on some of the problems and solutions to this with prep
Oskari and Flavio talk about how robots can help humans in biomedical research. UniteLabs is building lab automation systems to automate boring tasks so the highly trained researchers can focus on more high-level activit
What does Open Research mean for the Gates Foundation? Why does it matter? How are they implementing it? We speak with Ashley Farley who is in charge of those initiatives at the Gates Foundation.
In the 2nd part of the interview with Prof. Ernst Hafen we learn about how the birth of the Bio-Technopark Schlieren shows that if innovative entrepreneurs come together with great scientists, magic can happen. We also l
Lenny is the founder and CEO of protocols.io, where scientists can freely share scientific protocols with each other. Similarly to github, others can then try them out in their own lab, comment on them, improve them or f
In this episode, Prof. Ernst Hafen from ETH Zurich tells us how citizens can play a very important role in biomedical research and drug discovery. Recruiting the right patients for a study is a big challenge for biotech
In this episode, we learn how Huntington's disease researcher Rachel Harding uses an open lab notebook to share her findings with the scientific community and writes a blog for a wider audience. Most science is not condu
Sarah Constantin is a mathematician & data scientist with a PhD from Yale. We discover how computer vision and machine learning can be used to do drug discovery what the biggest challenges in today's cancer research with
Prof Paul Glasziou is a practitioner and widely published clinical research expert. He explains how we waste billions of dollars on biomedical research. Over 50% of all health research does not get published at all. From
In this podcast, we get to know Marcio van Muehlen, a biological engineer from MIT turned entrepreneur & product manager in Silicon Valley. He was working on cancer diagnostics through blood sampling and wanted to have b
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Bio2040 - Bottlenecks & Future of Science, Healthcare & Biotech has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their science audience.
Bio2040 - Bottlenecks & Future of Science, Healthcare & Biotech is hosted by Flavio Rump. The show is categorised under Science (Life) and has published 15 episodes.
Bio2040 - Bottlenecks & Future of Science, Healthcare & Biotech has published 15 episodes.
Bio2040 - Bottlenecks & Future of Science, Healthcare & Biotech regularly covers Science, Life. It sits in the Science category, with a Life focus.
Bio2040 - Bottlenecks & Future of Science, Healthcare & Biotech is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Bio2040 - Bottlenecks & Future of Science, Healthcare & Biotech hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Bio2040 - Bottlenecks & Future of Science, Healthcare & Biotech average 41 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Bio2040 - Bottlenecks & Future of Science, Healthcare & Biotech's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched yesterday.